- AI
- Molecular Imaging
- CT
- X-Ray
- Ultrasound
- MRI
- Facility Management
- Mammography
Epix completes study enrollment
Contrast media developer Epix Medical has completed enrollment in the second of two phase III trials designed to detect peripheral vascular disease in the aortoiliac arteries using the company¹s new blood pool MR agent, MS-325. The company expects to
Contrast media developer Epix Medical has completed enrollment in the second of two phase III trials designed to detect peripheral vascular disease in the aortoiliac arteries using the company¹s new blood pool MR agent, MS-325. The company expects to complete a review of the data and release results in spring 2003. Positive study results from the first trial were reported last March at the annual American College of Cardiology meeting. Epix continues to enroll patients in the remaining two phase III clinical trials aimed at detecting peripheral vascular disease in the renal and pedal arteries. Enrollment in these trials should be completed in the first quarter of 2003. Epix plans to file a new drug application with the FDA for MS-325 approximately six months after enrollment is completed.
MRI-Based AI Radiomics Model Offers 'Robust' Prediction of Perineural Invasion in Prostate Cancer
July 26th 2024A model that combines MRI-based deep learning radiomics and clinical factors demonstrated an 84.8 percent ROC AUC and a 92.6 percent precision-recall AUC for predicting perineural invasion in prostate cancer cases.
Breast MRI Study Examines Common Factors with False Negatives and False Positives
July 24th 2024The absence of ipsilateral breast hypervascularity is three times more likely to be associated with false-negative findings on breast MRI and non-mass enhancement lesions have a 4.5-fold likelihood of being linked to false-positive results, according to new research.
Can Polyenergetic Reconstruction Help Resolve Streak Artifacts in Photon Counting CT?
July 22nd 2024New research looking at photon-counting computed tomography (PCCT) demonstrated significantly reduced variation and tracheal air density attenuation with polyenergetic reconstruction in contrast to monoenergetic reconstruction on chest CT.
